Yale professor Craig Crews says the partnershop reflects "a new paradigm" of how academics and the pharmaceutical industry can partner.
UK-based pharmaceutical company GlaxoSmithKline and US-based Yale University [the Beinecke Library is pictured] set up a drug discovery research collaboration on Tuesday last week. The partnership is designed to develop Yale’s work on "proteolysis targeting chimeric molecules", which help the body destroy disease-causing proteins. The two institutions are looking to show these molecules can be…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
